Comparison of 11 phenotypic assays for accurate detection of carbapenemase- producing enterobacteriaceae

Pranita Tamma, Belita N A Opene, Andrew Gluck, Krizia K. Chambers, Karen C Carroll, Patricia Simner

Research output: Contribution to journalArticle

Abstract

Early identification of carbapenemase-producing Enterobacteriaceae (CPE) is essential to prevent their dissemination within health care settings. Our objective was to evaluate the accuracy of 11 phenotypic assays for the detection of CPE. Two collections of carbapenem-resistant Enterobacteriaceae (CRE) isolates were evaluated, including 191 retrospective isolates (122 CP-CRE and 69 non-CP isolates) as well as 45 prospective clinical isolates (15 CP-CRE and 30 non-CP-CRE) obtained over a 3-month period. The sensitivity and specificity of each test was determined, with molecular genotype serving as the gold standard. Among the retrospective cohort, sensitivities ranged from 72% for the boronic acid synergy test for the detection of KPC producers to β98% for the modified Carba NP, the Rapidec Carba NP, the manual Blue Carba, and the modified carbapenem inactivation method for the detection of any CPE. Sensitivity differed among tests across enzyme classes. All assays had excellent specificity exceeding 95%, with the exception of the boronic acid synergy test (88%) and modified Hodge test (91%). Prospectively, 45 CRE isolates were encountered over a 3-month period, including 15 CPE (33%) and 30 non-CPCRE (67%). Results from the prospective cohort were similar. However, a decrease in specificity was observed across most tests, likely due to restricted inclusion of non- CP-CRE to assess the specificity of the assays. Overall, accuracy of CPE detection varied across phenotypic tests. Local epidemiology of CP genotypes, turnaround time, and ease of incorporation into the laboratory workflow should be considered when selecting a phenotypic assay for clinical use.

Original languageEnglish (US)
Pages (from-to)1046-1055
Number of pages10
JournalJournal of Clinical Microbiology
Volume55
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Enterobacteriaceae
Carbapenems
Boronic Acids
carbapenemase
Genotype
Workflow
Epidemiology
Delivery of Health Care
Sensitivity and Specificity

Keywords

  • Carbapenem-resistant organisms
  • Carbapenemase-producing organisms
  • Prevalence

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Comparison of 11 phenotypic assays for accurate detection of carbapenemase- producing enterobacteriaceae. / Tamma, Pranita; Opene, Belita N A; Gluck, Andrew; Chambers, Krizia K.; Carroll, Karen C; Simner, Patricia.

In: Journal of Clinical Microbiology, Vol. 55, No. 4, 01.04.2017, p. 1046-1055.

Research output: Contribution to journalArticle

@article{54dbd7b43cf54a349cde55061b33f979,
title = "Comparison of 11 phenotypic assays for accurate detection of carbapenemase- producing enterobacteriaceae",
abstract = "Early identification of carbapenemase-producing Enterobacteriaceae (CPE) is essential to prevent their dissemination within health care settings. Our objective was to evaluate the accuracy of 11 phenotypic assays for the detection of CPE. Two collections of carbapenem-resistant Enterobacteriaceae (CRE) isolates were evaluated, including 191 retrospective isolates (122 CP-CRE and 69 non-CP isolates) as well as 45 prospective clinical isolates (15 CP-CRE and 30 non-CP-CRE) obtained over a 3-month period. The sensitivity and specificity of each test was determined, with molecular genotype serving as the gold standard. Among the retrospective cohort, sensitivities ranged from 72{\%} for the boronic acid synergy test for the detection of KPC producers to β98{\%} for the modified Carba NP, the Rapidec Carba NP, the manual Blue Carba, and the modified carbapenem inactivation method for the detection of any CPE. Sensitivity differed among tests across enzyme classes. All assays had excellent specificity exceeding 95{\%}, with the exception of the boronic acid synergy test (88{\%}) and modified Hodge test (91{\%}). Prospectively, 45 CRE isolates were encountered over a 3-month period, including 15 CPE (33{\%}) and 30 non-CPCRE (67{\%}). Results from the prospective cohort were similar. However, a decrease in specificity was observed across most tests, likely due to restricted inclusion of non- CP-CRE to assess the specificity of the assays. Overall, accuracy of CPE detection varied across phenotypic tests. Local epidemiology of CP genotypes, turnaround time, and ease of incorporation into the laboratory workflow should be considered when selecting a phenotypic assay for clinical use.",
keywords = "Carbapenem-resistant organisms, Carbapenemase-producing organisms, Prevalence",
author = "Pranita Tamma and Opene, {Belita N A} and Andrew Gluck and Chambers, {Krizia K.} and Carroll, {Karen C} and Patricia Simner",
year = "2017",
month = "4",
day = "1",
doi = "10.1128/JCM.02338-16",
language = "English (US)",
volume = "55",
pages = "1046--1055",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Comparison of 11 phenotypic assays for accurate detection of carbapenemase- producing enterobacteriaceae

AU - Tamma, Pranita

AU - Opene, Belita N A

AU - Gluck, Andrew

AU - Chambers, Krizia K.

AU - Carroll, Karen C

AU - Simner, Patricia

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Early identification of carbapenemase-producing Enterobacteriaceae (CPE) is essential to prevent their dissemination within health care settings. Our objective was to evaluate the accuracy of 11 phenotypic assays for the detection of CPE. Two collections of carbapenem-resistant Enterobacteriaceae (CRE) isolates were evaluated, including 191 retrospective isolates (122 CP-CRE and 69 non-CP isolates) as well as 45 prospective clinical isolates (15 CP-CRE and 30 non-CP-CRE) obtained over a 3-month period. The sensitivity and specificity of each test was determined, with molecular genotype serving as the gold standard. Among the retrospective cohort, sensitivities ranged from 72% for the boronic acid synergy test for the detection of KPC producers to β98% for the modified Carba NP, the Rapidec Carba NP, the manual Blue Carba, and the modified carbapenem inactivation method for the detection of any CPE. Sensitivity differed among tests across enzyme classes. All assays had excellent specificity exceeding 95%, with the exception of the boronic acid synergy test (88%) and modified Hodge test (91%). Prospectively, 45 CRE isolates were encountered over a 3-month period, including 15 CPE (33%) and 30 non-CPCRE (67%). Results from the prospective cohort were similar. However, a decrease in specificity was observed across most tests, likely due to restricted inclusion of non- CP-CRE to assess the specificity of the assays. Overall, accuracy of CPE detection varied across phenotypic tests. Local epidemiology of CP genotypes, turnaround time, and ease of incorporation into the laboratory workflow should be considered when selecting a phenotypic assay for clinical use.

AB - Early identification of carbapenemase-producing Enterobacteriaceae (CPE) is essential to prevent their dissemination within health care settings. Our objective was to evaluate the accuracy of 11 phenotypic assays for the detection of CPE. Two collections of carbapenem-resistant Enterobacteriaceae (CRE) isolates were evaluated, including 191 retrospective isolates (122 CP-CRE and 69 non-CP isolates) as well as 45 prospective clinical isolates (15 CP-CRE and 30 non-CP-CRE) obtained over a 3-month period. The sensitivity and specificity of each test was determined, with molecular genotype serving as the gold standard. Among the retrospective cohort, sensitivities ranged from 72% for the boronic acid synergy test for the detection of KPC producers to β98% for the modified Carba NP, the Rapidec Carba NP, the manual Blue Carba, and the modified carbapenem inactivation method for the detection of any CPE. Sensitivity differed among tests across enzyme classes. All assays had excellent specificity exceeding 95%, with the exception of the boronic acid synergy test (88%) and modified Hodge test (91%). Prospectively, 45 CRE isolates were encountered over a 3-month period, including 15 CPE (33%) and 30 non-CPCRE (67%). Results from the prospective cohort were similar. However, a decrease in specificity was observed across most tests, likely due to restricted inclusion of non- CP-CRE to assess the specificity of the assays. Overall, accuracy of CPE detection varied across phenotypic tests. Local epidemiology of CP genotypes, turnaround time, and ease of incorporation into the laboratory workflow should be considered when selecting a phenotypic assay for clinical use.

KW - Carbapenem-resistant organisms

KW - Carbapenemase-producing organisms

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85016198921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016198921&partnerID=8YFLogxK

U2 - 10.1128/JCM.02338-16

DO - 10.1128/JCM.02338-16

M3 - Article

C2 - 28077701

AN - SCOPUS:85016198921

VL - 55

SP - 1046

EP - 1055

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -